Hepion Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $9.3M | $18.4M | $13.0M |
| FY2018 | $6.2M | $8.2M | $2.8M |
| FY2019 | $5.0M | $20.6M | $13.9M |
| FY2020 | $8.1M | $48.6M | $40.7M |
| FY2021 | $10.6M | $103.6M | $91.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $9.3M | $18.4M | $13.0M |
| FY2018 | $6.2M | $8.2M | $2.8M |
| FY2019 | $5.0M | $20.6M | $13.9M |
| FY2020 | $8.1M | $48.6M | $40.7M |
| FY2021 | $10.6M | $103.6M | $91.3M |